Public Offering of Convertible Notes By Medical Products Company

Faegre Baker Daniels advised on a $230 million public offering of convertible notes of a medical products company.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.